Literature DB >> 24271788

Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model.

Manuela Polydoro1, Volodymyr I Dzhala, Amy M Pooler, Samantha B Nicholls, A Patrick McKinney, Laura Sanchez, Rose Pitstick, George A Carlson, Kevin J Staley, Tara L Spires-Jones, Bradley T Hyman.   

Abstract

Neurofibrillary tangles (NFTs), a hallmark of Alzheimer's disease, are intracellular silver and thioflavin S-staining aggregates that emerge from earlier accumulation of phospho-tau in the soma. Whether soluble misfolded but nonfibrillar tau disrupts neuronal function is unclear. Here we investigate if soluble pathological tau, specifically directed to the entorhinal cortex (EC), can cause behavioral or synaptic deficits. We studied rTgTauEC transgenic mice, in which P301L mutant human tau overexpressed primarily in the EC leads to the development of tau pathology, but only rare NFT at 16 months of age. We show that the early tau lesions are associated with nearly normal performance in contextual fear conditioning, a hippocampal-related behavior task, but more robust changes in neuronal system activation as marked by Arc induction and clear electrophysiological defects in perforant pathway synaptic plasticity. Electrophysiological changes were likely due to a presynaptic deficit and changes in probability of neurotransmitter release. The data presented here support the hypothesis that misfolded and hyperphosphorylated tau can impair neuronal function within the entorhinal-hippocampal network, even prior to frank NFT formation and overt neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24271788      PMCID: PMC3946978          DOI: 10.1007/s00401-013-1215-5

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  63 in total

1.  Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.

Authors:  G A Jicha; R Bowser; I G Kazam; P Davies
Journal:  J Neurosci Res       Date:  1997-04-15       Impact factor: 4.164

2.  CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory.

Authors:  Masahiro Yasuda; Mark R Mayford
Journal:  Neuron       Date:  2006-04-20       Impact factor: 17.173

3.  Long-term potentiation selectively expressed by NMDA receptors at hippocampal mossy fiber synapses.

Authors:  Hyung-Bae Kwon; Pablo E Castillo
Journal:  Neuron       Date:  2008-01-10       Impact factor: 17.173

4.  Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release.

Authors:  D Debanne; N C Guérineau; B H Gähwiler; S M Thompson
Journal:  J Physiol       Date:  1996-02-15       Impact factor: 5.182

5.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

6.  Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.

Authors:  Manuela Polydoro; Christopher M Acker; Karen Duff; Pablo E Castillo; Peter Davies
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

7.  Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain.

Authors:  H Ksiezak-Reding; P Davies; S H Yen
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

8.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.

Authors:  Y P Wang; J Biernat; M Pickhardt; E Mandelkow; E-M Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

9.  Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories.

Authors:  Niels Plath; Ora Ohana; Björn Dammermann; Mick L Errington; Dietmar Schmitz; Christina Gross; Xiaosong Mao; Arne Engelsberg; Claudia Mahlke; Hans Welzl; Ursula Kobalz; Anastasia Stawrakakis; Esperanza Fernandez; Robert Waltereit; Anika Bick-Sander; Eric Therstappen; Sam F Cooke; Veronique Blanquet; Wolfgang Wurst; Benedikt Salmen; Michael R Bösl; Hans-Peter Lipp; Seth G N Grant; Tim V P Bliss; David P Wolfer; Dietmar Kuhl
Journal:  Neuron       Date:  2006-11-09       Impact factor: 17.173

10.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

View more
  42 in total

Review 1.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

2.  Tau pathology-mediated presynaptic dysfunction.

Authors:  H Moreno; G Morfini; L Buitrago; G Ujlaki; S Choi; E Yu; J E Moreira; J Avila; S T Brady; H Pant; M Sugimori; R R Llinás
Journal:  Neuroscience       Date:  2016-03-21       Impact factor: 3.590

Review 3.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

4.  AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.

Authors:  A Borreca; V Latina; V Corsetti; S Middei; S Piccinin; F Della Valle; R Bussani; M Ammassari-Teule; R Nisticò; P Calissano; G Amadoro
Journal:  Mol Neurobiol       Date:  2018-03-05       Impact factor: 5.590

5.  Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer's Disease.

Authors:  Hongjun Fu; Gustavo A Rodriguez; Mathieu Herman; Sheina Emrani; Eden Nahmani; Geoffrey Barrett; Helen Y Figueroa; Eliana Goldberg; S Abid Hussaini; Karen E Duff
Journal:  Neuron       Date:  2017-01-19       Impact factor: 17.173

6.  Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.

Authors:  Emily J Koller; Elsa Gonzalez De La Cruz; Timothy Machula; Kristen R Ibanez; Wen-Lang Lin; Tosha Williams; Cara J Riffe; Daniel Ryu; Kevin H Strang; Xuefei Liu; Christopher Janus; Todd E Golde; Dennis Dickson; Benoit I Giasson; Paramita Chakrabarty
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

7.  The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity.

Authors:  Jochen Martin Decker; Lars Krüger; Astrid Sydow; Frank Ja Dennissen; Zuzana Siskova; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  EMBO Rep       Date:  2016-03-01       Impact factor: 8.807

8.  DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins.

Authors:  Sarah N Fontaine; Dali Zheng; Jonathan J Sabbagh; Mackenzie D Martin; Dale Chaput; April Darling; Justin H Trotter; Andrew R Stothert; Bryce A Nordhues; April Lussier; Jeremy Baker; Lindsey Shelton; Mahnoor Kahn; Laura J Blair; Stanley M Stevens; Chad A Dickey
Journal:  EMBO J       Date:  2016-06-03       Impact factor: 11.598

Review 9.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

10.  Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.

Authors:  Nabila Boukelmoune; Geoffroy Laumet; Yongfu Tang; Jiacheng Ma; Itee Mahant; Susmita K Singh; Cora Nijboer; Manon Benders; Annemieke Kavelaars; Cobi J Heijnen
Journal:  Brain Behav Immun       Date:  2020-12-11       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.